Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paroxetine CR in Major Depressive Disorder
NCT00866294Phase 3Completed
- Sponsor
- GSK
- Start
- Apr 2009
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of paroxetine in major depressive disorder (MDD), sponsored by GSK. Started Apr 2009; status: completed.
02
Drugs
paroxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00866294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00866294.